Cabot Corp has a consensus price target of $89, established from looking at the 22 latest analyst ratings. The last 3 analyst ratings were released from UBS, Mizuho, and Deutsche Bank on May 7, 2024, May 7, 2024, and April 18, 2024. With an average price target of $102.33 between UBS, Mizuho, and Deutsche Bank, there's an implied 1.25% upside for Cabot Corp from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|
The latest price target for Cabot (NYSE: CBT) was reported by UBS on May 7, 2024. The analyst firm set a price target for $103.00 expecting CBT to rise to within 12 months (a possible 1.91% upside). 12 analyst firms have reported ratings in the last year.
The latest analyst rating for Cabot (NYSE: CBT) was provided by UBS, and Cabot maintained their neutral rating.
The last upgrade for Cabot Corp happened on November 16, 2022 when Deutsche Bank raised their price target to $90. Deutsche Bank previously had a hold for Cabot Corp.
The last downgrade for Cabot Corp happened on April 18, 2024 when Deutsche Bank changed their price target from $88 to $95 for Cabot Corp.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cabot, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cabot was filed on May 7, 2024 so you should expect the next rating to be made available sometime around May 7, 2025.
While ratings are subjective and will change, the latest Cabot (CBT) rating was a maintained with a price target of $100.00 to $103.00. The current price Cabot (CBT) is trading at is $101.07, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.